RTS forms Vision Technology Business Unit

Sensor Review

ISSN: 0260-2288

Article publication date: 28 June 2011



(2011), "RTS forms Vision Technology Business Unit", Sensor Review, Vol. 31 No. 3. https://doi.org/10.1108/sr.2011.08731caa.006



Emerald Group Publishing Limited

Copyright © 2011, Emerald Group Publishing Limited

RTS forms Vision Technology Business Unit

Article Type: News From: Sensor Review, Volume 31, Issue 3

ENTOLOGI, the UK engineering group, is radically restructuring its latest acquisition, RTS Life Science, along technology specialisms. The first new Business Unit to be formed is Vision Technology.

Carl Krajewski, CEO of Entologi explains: “We’ve analysed the business closely and have identified key growth opportunities in both the life science and industrial sectors for our vision capabilities and products. Our specialist Vision Development Team has deployed its technology successfully in numerous applications from machine vision on robotic production lines to Biobanking. We believe that our investment and focus should propel the Vision Technology Business Unit into a leading position in the commercial application of machine vision worldwide.”

The RTS Vision Technology Business Unit contains a core team of vision and software specialists who have devoted themselves to the advancement of this technology since 1996. They will continue to deliver the custom machine vision solutions they are best known for. However, they will also work on developing a range of products with machine vision at their centre. These products are likely to have manufacturing, laboratory and warehouse applications and may well also draw on the Entologi Group’s robotic heritage.

Chris Walsh has been promoted to be Director of the Vision Technology Business Unit at RTS. He comments: “RTS has always been well known for its vision solutions in the packaging automation sector. More recently we have employed the same expertise to develop innovative products for the life science marketplace, including RTS’s Tube Auditor and Automated Blood Fractionation systems. By focussing our vision capabilities into a dedicated business unit, the Entologi Group should benefit commercially and the discipline of Machine Vision should benefit technologically.”

For further information, please visit: www.entologi.com

Related articles